Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cell Death Differ ; 18(2): 191-200, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21217767

RESUMO

Huntington's disease (HD) is a fatal neurodegenerative disorder caused by expansion of a polyglutamine tract in the huntingtin protein (htt) that mediates formation of intracellular protein aggregates. In the brains of HD patients and HD transgenic mice, accumulation of protein aggregates has been causally linked to lesions in axo-dendritic and synaptic compartments. Here we show that dendritic spines - sites of synaptogenesis - are lost in the proximity of htt aggregates because of functional defects in local endosomal recycling mediated by the Rab11 protein. Impaired exit from recycling endosomes (RE) and association of endocytosed protein with intracellular structures containing htt aggregates was demonstrated in cultured hippocampal neurons cells expressing a mutant htt fragment. Dendrites in hippocampal neurons became dystrophic around enlarged amphisome-like structures positive for Rab11, LC3 and mutant htt aggregates. Furthermore, Rab11 overexpression rescues neurodegeneration and dramatically extends lifespan in a Drosophila model of HD. Our findings are consistent with the model that mutant htt aggregation increases local autophagic activity, thereby sequestering Rab11 and diverting spine-forming cargo from RE into enlarged amphisomes. This mechanism may contribute to the toxicity caused by protein misfolding found in a number of neurodegenerative diseases.


Assuntos
Espinhas Dendríticas/ultraestrutura , Doença de Huntington/metabolismo , Proteínas rab de Ligação ao GTP/metabolismo , Animais , Espinhas Dendríticas/metabolismo , Modelos Animais de Doenças , Drosophila/metabolismo , Endossomos/metabolismo , Proteína Huntingtina , Doença de Huntington/patologia , Camundongos , Camundongos Transgênicos , Proteínas do Tecido Nervoso/genética , Proteínas do Tecido Nervoso/metabolismo , Neurônios/metabolismo , Neurônios/patologia , Proteínas Nucleares/genética , Proteínas Nucleares/metabolismo , Células PC12 , Ratos
2.
Cell Death Differ ; 9(8): 818-31, 2002 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12107825

RESUMO

Neuronal death, which follows ischemic injury or is triggered by excitotoxins, can occur by both apoptosis and necrosis. Caspases, which are not directly required for necrotic cell death, are central mediators of the apoptotic program. Here we demonstrate that caspases cleave and inactivate the plasma membrane Ca(2+) pump (PMCA) in neurons and non-neuronal cells undergoing apoptosis. PMCA cleavage impairs intracellular Ca(2+) handling, which results in Ca(2+) overload. Expression of non-cleavable PMCA mutants prevents the disturbance in Ca(2+) handling, slows down the kinetics of apoptosis, and markedly delays secondary cell lysis (necrosis). These findings suggest that caspase-mediated cleavage and inactivation of PMCAs can lead to necrosis, an event that is reduced by caspase inhibitors in brain ischemia.


Assuntos
Apoptose/fisiologia , ATPases Transportadoras de Cálcio/metabolismo , Caspases/metabolismo , Membrana Celular/enzimologia , Hipóxia-Isquemia Encefálica/enzimologia , Necrose , Neurônios/enzimologia , Animais , Animais Recém-Nascidos , Apoptose/efeitos dos fármacos , Sítios de Ligação/efeitos dos fármacos , Sítios de Ligação/fisiologia , Células CHO , Cálcio/metabolismo , Sinalização do Cálcio/efeitos dos fármacos , Sinalização do Cálcio/fisiologia , ATPases Transportadoras de Cálcio/efeitos dos fármacos , Caspase 3 , Caspases/efeitos dos fármacos , Caspases/genética , Proteínas de Transporte de Cátions , Membrana Celular/efeitos dos fármacos , Células Clonais/citologia , Células Clonais/efeitos dos fármacos , Células Clonais/metabolismo , Corantes , Cricetinae , Hipóxia-Isquemia Encefálica/patologia , Hipóxia-Isquemia Encefálica/fisiopatologia , Imuno-Histoquímica , Líquido Intracelular/metabolismo , Camundongos , Mutação/efeitos dos fármacos , Mutação/genética , Neurônios/efeitos dos fármacos , Neurônios/patologia , Neurotoxinas/farmacologia , ATPases Transportadoras de Cálcio da Membrana Plasmática , Ratos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...